TY - JOUR
T1 - Clinicopathological Characteristics of Patients with HR-Positive/HER2-Negative Metastatic Breast Cancer Experiencing Early Progression Within 6 Months of CDK4/6 Inhibitor Therapy
Y1 - 2026
PY - 2026
DA - 2026
N1 - doi:269433
T2 - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JF - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION
JO - EJMI
SP - 433
EP - 440
VL - 10
IS - 3
SN - 
M3 - doi:269433
UR - https://dx.doi.org/10.14744/ejmi.269433
Y2 - 2026
ER -